The west of Scotland Coronary Prevention study: A trial of cholesterol reduction in scottish men

This publication has 14 references indexed in Scilit:

• Influence of Pravastatin, a Specific Inhibitor of HMG-CoA Reductase, on Hepatic Metabolism of Cholesterol
  New England Journal of Medicine, 1990
• Disposition of pravastatin sodium, a tissue‐selective HMG‐CoA reductase inhibitor, in healthy subjects.
  British Journal of Clinical Pharmacology, 1990
• Pravastatin therapy in primary moderate hypercholesterolaemia: changes in metabolism of apolipoprotein B‐containing lipoproteins
  Journal of Internal Medicine, 1990
• Pravastatin Sodium: A Novel Cholesterol‐Lowering Agent that Inhibits HMG‐CoA Reductase
  Cardiovascular Drug Reviews, 1989
• Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
  New England Journal of Medicine, 1987
• The Helsinki Heart Study: Basic design and randomization procedure
  European Heart Journal, 1987
• CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
• The Lipid Research Clinics Coronary Primary Prevention Trial Results
  JAMA, 1984
• The coronary primary prevention trial: Design and implementation
  Journal of Chronic Diseases, 1979
• A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.
  Heart, 1978